• News
  • Life
  • TV & Film
  • Beauty
  • Style
  • Home
  • News
    • Celebrity
    • Entertainment
    • Politics
    • Royal Family
  • Life
    • Animals
    • Food & Drink
    • Women's Health
    • Mental Health
    • Sex & Relationships
    • Travel
    • Real Life
  • TV & Film
    • True Crime
    • Documentaries
    • Netflix
    • BBC
    • ITV
    • Tyla Recommends
  • Beauty
    • Hair
    • Make-up
    • Skincare
  • Style
    • Home
    • Fashion
    • Shopping
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
Submit Your Content
'Game-changing' breast cancer drug breakthrough offers lifeline to thousands of women

Home> Health

Updated 18:08 8 Dec 2022 GMTPublished 18:09 8 Dec 2022 GMT

'Game-changing' breast cancer drug breakthrough offers lifeline to thousands of women

It could offer hope to thousands of people affected by the disease.

Lucy Devine

Lucy Devine

A 'game-changing' new breast cancer drug could offer hope to thousands of people affected by the disease.

Scientists have said they've had a 'landmark moment' after the drug was found to slow the growth of breast cancer significantly.

A 'game-changing' new breast cancer drug could offer hope to thousands of people affected by the disease.
Norma Jean Gargasz/Alamy Stock Photo

Advert

The drug - named capivasertib - has been found to double the amount of time before the cancer progressed, and in a trial of 700 people, it shrunk the tumour in almost a quarter.

The phase III clinical trial found that in those taking the drug alongside hormone therapy, the cancer didn't progress for on average seven months.

In comparison, in those taking hormone therapy alone, the cancer took on average three and a half months to progress.

The results mean the new combination could become the latest treatment for those with oestrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER-2) negative breast cancer.

Advert

The trial found that in those taking the drug alongside hormone therapy, the cancer didn't progress for on average seven months.
Thomas Andreas/Alamy Stock Photo

Women with this type of cancer rely on hormone therapy to block estrogen, but many find the treatment becomes resistant to the tablets.

Capivasertib works in a different way to hormone therapy, effectively blocking a protein molecule called AKT which drives cancer cells to divide.

The findings of the trial were presented at the San Antonio Breast Cancer Symposium.

Advert

Speaking about the new drug, Linda Kelly, 65, who joined the trial joined the trial after her breast cancer spread to her bones and chest wall, said: “The results have been amazing. There has been a substantial reduction in my disease, my cancer has not progressed, and I haven’t had any new tumours.

“The treatment is far less debilitating than chemotherapy and I’ve been given the gift of a longer life.”

The findings of the trial were presented at the San Antonio Breast Cancer Symposium.
Zoonar GmbH/Alamy Stock Photo

Nick Turner, professor of molecular oncology at the Institute of Cancer Research and consultant oncologist at the Royal Marsden led the trial.

Advert

He said: “This is a fantastic finding for patients with breast cancer.

“Even with the best current treatments, people with this type of advanced breast cancer will eventually see their cancer stop responding to treatment, and it will progress.

“We’re delighted that this potential first-in-class drug combined with hormone therapy can lower the progression of these advanced cancers, and in almost a third of cases can shrink tumours.

“We believe this new treatment could allow more women and men to live well and live longer with breast cancer.”

Advert

Professor Kristian Helin, chief executive of the ICR, added: “This is a landmark moment for the treatment of advanced forms of the most common type of breast cancer.

“Capivasertib could offer a completely new treatment option for these patients.

“This is a major success story for UK science – the discovery and development of capivasertib showcases the benefits of collaboration between academia, charities and industry to bring game-changing new treatments to people with cancer as quickly as possible.”

Featured Image Credit: Phanie/agefotostock/Alamy Stock Photo

Topics: Health

Lucy Devine
Lucy Devine

Lucy is a journalist working for Tyla. After graduating with a master's degree in journalism, she has worked in both print and online and is particularly interested in fashion, food, health and women's issues. Northerner, coffee addict, says hun a lot.

X

@lucedevine

Advert

Advert

Advert

Choose your content:

a year ago
  • a year ago

    Girl, 10, diagnosed with ‘most painful condition’ known to mankind

    She can't even hug her own family as the pain is so severe

    Health
  • a year ago

    Fitness influencer, 53, sparks controversy after working out in London cemetery

    Andrea Sunshine faced some backlash for her choice to work out in a cemetery

    Health
  • a year ago

    Woman told by doctors her cancer was ‘too rare to return’ has died aged 30

    The woman was left devastated after learning the cancer had returned

    Health
  • a year ago

    Expert shares why you shouldn't wipe more than three times after doing a number two

    TikTok user George, who is a pelvic floor physiotherapist, has explained why you shouldn't be wiping more than three times

    Health
  • Four skin changes to look out for that could be a sign of breast cancer
  • First ever head-to-head trial of Mounjaro and Wegovy reveals which one is a more effective weight-loss drug
  • Little known signs of PCOS that you might be ignoring as thousands of women remain undiagnosed
  • Experts issue warning that tattoos may increase the risk of developing of two types of cancer